Shenyang Xingqi Pharmaceutical Co Ltd
Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic medications in the People's Republic of China. The company provides myopia prevention and control medications, nutrition and corneal repair drugs, ophthalmic anti-inflammatory/anti-infective drugs, artificial tears and eye lubricants, ophthalmic non-steroidal anti-inflammatory drugs… Read more
Shenyang Xingqi Pharmaceutical Co Ltd (300573) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.145x
Based on the latest financial reports, Shenyang Xingqi Pharmaceutical Co Ltd (300573) has a cash flow conversion efficiency ratio of 0.145x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥268.97 Million) by net assets (CN¥1.86 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shenyang Xingqi Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Shenyang Xingqi Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shenyang Xingqi Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenyang Xingqi Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wuxi Nce Power Co Ltd
SHG:605111
|
0.030x |
|
The Chemours Company
MX:CC
|
0.487x |
|
Companhia de Saneamento de Minas Gerais
SA:CSMG3
|
0.057x |
|
PT Barito Pacific Tbk
F:OB8
|
-0.007x |
|
Valeo SE
PINK:VLEEF
|
0.285x |
|
Yantai Moon Co Ltd
SHE:000811
|
0.046x |
|
HTC Corporation
OTCGREY:HTCKF
|
-0.016x |
|
Organon & Co
NYSE:OGN
|
0.291x |
Annual Cash Flow Conversion Efficiency for Shenyang Xingqi Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Shenyang Xingqi Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.59 Billion | CN¥416.98 Million | 0.262x | +39.28% |
| 2023-12-31 | CN¥1.69 Billion | CN¥317.57 Million | 0.188x | +1.90% |
| 2022-12-31 | CN¥1.55 Billion | CN¥286.26 Million | 0.184x | -19.23% |
| 2021-12-31 | CN¥1.34 Billion | CN¥306.96 Million | 0.228x | +29.72% |
| 2020-12-31 | CN¥694.06 Million | CN¥122.16 Million | 0.176x | +36.59% |
| 2019-12-31 | CN¥574.90 Million | CN¥74.08 Million | 0.129x | +62.38% |
| 2018-12-31 | CN¥554.58 Million | CN¥44.01 Million | 0.079x | +34.31% |
| 2017-12-31 | CN¥553.38 Million | CN¥32.70 Million | 0.059x | +9.45% |
| 2016-12-31 | CN¥520.95 Million | CN¥28.12 Million | 0.054x | -1.82% |
| 2015-12-31 | CN¥389.79 Million | CN¥21.43 Million | 0.055x | +55.59% |
| 2014-12-31 | CN¥367.81 Million | CN¥13.00 Million | 0.035x | +41.72% |
| 2013-12-31 | CN¥336.80 Million | CN¥8.40 Million | 0.025x | -82.72% |
| 2012-12-31 | CN¥290.70 Million | CN¥41.96 Million | 0.144x | +45.29% |
| 2011-12-31 | CN¥247.00 Million | CN¥24.54 Million | 0.099x | -- |